Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a ...

Travere Therapeutics' market cap has more than doubled in six months, reflecting confidence in FILSPARI's role in treating ...

BACKGROUND: Total energy expenditure (TEE) is estimated in clinical practice as a combined measure of resting energy expenditure and physical activity level. Commonly available questionnaires to ...

A previously described 18F-labeled bisAmBF3 derivative of PSMA617, named [18F]HTK-01174, has been shown to have increased tumor uptake and decreased liver uptake as compared to FDA-approved 18F-DCFPyL ...

Scientists at UC San Francisco are working on a new approach to treating kidney failure that could one day free people from needing dialysis or having to take harsh drugs to suppress their immune ...

The REMODEL trial testing semaglutide’s efficacy in patients with CKD and T2DM also employed MRI, transcriptomics, blood and urine samples, and kidney biopsies to clarify the drug’s effects.

Next-Generation Gummies for People Living with Chronic Kidney Disease EXTON, Pa., Nov. 20, 2025 /PRNewswire/ -- Kibow Biotech, a leading innovator of superior probiotic supplements for maintaining ...